{"name":"Valenta Pharm JSC","slug":"valenta-pharm-jsc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"oncology","drugs":[{"name":"Afobazole","genericName":"Afobazole","slug":"afobazole","indication":"Other","status":"marketed"},{"name":"Antareit","genericName":"Antareit","slug":"antareit","indication":"Other","status":"phase_1"},{"name":"Imidazolyl ethanamide pentandioic acid","genericName":"Imidazolyl ethanamide pentandioic acid","slug":"imidazolyl-ethanamide-pentandioic-acid","indication":"Other","status":"phase_3"},{"name":"Septolete Total","genericName":"Septolete Total","slug":"septolete-total","indication":"Other","status":"phase_2"},{"name":"Vespireit","genericName":"Vespireit","slug":"vespireit","indication":"Other","status":"marketed"},{"name":"4-MUST","genericName":"4-MUST","slug":"4-must","indication":"Other","status":"phase_2"},{"name":"Arlevert","genericName":"Arlevert","slug":"arlevert","indication":"Other","status":"marketed"},{"name":"Aterixen","genericName":"Aterixen","slug":"aterixen","indication":"Other","status":"phase_1"},{"name":"Hydroxymethylquinoxalindioxyde","genericName":"Hydroxymethylquinoxalindioxyde","slug":"hydroxymethylquinoxalindioxyde","indication":"Other","status":"phase_3"},{"name":"Ranquilon","genericName":"Ranquilon","slug":"ranquilon","indication":"Other","status":"marketed"},{"name":"Trimedat®","genericName":"Trimedat®","slug":"trimedat","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"XC8","genericName":"XC8","slug":"xc8","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Afobazole","genericName":"Afobazole","slug":"afobazole","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"XC8","genericName":"XC8","slug":"xc8","phase":"phase_3","mechanism":"XC8 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Antareit","genericName":"Antareit","slug":"antareit","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Imidazolyl ethanamide pentandioic acid","genericName":"Imidazolyl ethanamide pentandioic acid","slug":"imidazolyl-ethanamide-pentandioic-acid","phase":"phase_3","mechanism":"Imidazolyl ethanamide pentandioic acid is a small-molecule compound that likely acts as a metabolic modulator or cellular signaling agent, though its precise mechanism remains proprietary.","indications":[],"catalyst":""},{"name":"Septolete Total","genericName":"Septolete Total","slug":"septolete-total","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vespireit","genericName":"Vespireit","slug":"vespireit","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"4-MUST","genericName":"4-MUST","slug":"4-must","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Arlevert","genericName":"Arlevert","slug":"arlevert","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Aterixen","genericName":"Aterixen","slug":"aterixen","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hydroxymethylquinoxalindioxyde","genericName":"Hydroxymethylquinoxalindioxyde","slug":"hydroxymethylquinoxalindioxyde","phase":"phase_3","mechanism":"Hydroxymethylquinoxalindioxyde is a quinoxaline derivative that likely acts as an antioxidant or free radical scavenger to reduce oxidative stress-related cellular damage.","indications":[],"catalyst":""},{"name":"Ranquilon","genericName":"Ranquilon","slug":"ranquilon","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Trimedat®","genericName":"Trimedat®","slug":"trimedat","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNQ01DOFhRX0NRM3hMSGhMT19aa054VTc0M3FXbnZOdldiQ1pYTUxCaVZoRDFaV3BVTE0yampmT2hqVVhzTW1mUTJQeHFHR09iaDVRYjEtQ3g1TUhPX21XemlQS1FBVzRUeTc2aTMtZjlHRG82MXRvY29Xd1pyN2JkQW9GSWhuT1BobkFpVFRvV3dOb2dpT0QzQURpWVduNlhONkVKQXpaLWk5ME9lUllTTmgyVGF1UQ?oc=5","date":"2022-02-16","type":"pipeline","source":"Newsweek","summary":"Russian Skater Kamila Valieva Reportedly Took Three Drugs—Here’s What to Know About Them - Newsweek","headline":"Russian Skater Kamila Valieva Reportedly Took Three Drugs—Here’s What to Know About Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOSVdDcGp2WHlPNzFLVmRSeWNBWlhyNGFvUWttdW1ZdkFzeVRXTWhkZ3dXanBKdGswMWxrR3BqamhrRU8xeGp5VC01S2R4MU5ydVlqbVlQanBhQ01vZXMzeXcxVU5DUE55MWEweUlfTzVYTGMwQ2N1V1dhN2I3S01YaUtxR0NSbXdQRGhZUWgyQkIzV0YxaEpSbHFWSEdyOXRWaTAxR0dfS3pHYnFRLWZF0gGvAUFVX3lxTE5JV0NwanZYeU83MUtWZFJ5Y0FaWHI0YW9Ra211bVl2QXN5VFdNaGRnd1dqcEp0azAxbGtHcGpqaGtFTzF4anlULTVLZHgxTnJ1WWptWVBqcGFDTW9lczN5dzFVTkNQTnkxYTB5SV9PNVhMYzBDY3VXV2E3YjdLTVhpS3FHQ1Jtd1BEaFlRaDJCQjNXRjFoSlJscVZIR3I5dFZpMDFHR19LekdicVEtZkU?oc=5","date":"2021-03-19","type":"pipeline","source":"Новости GxP","summary":"Valenta Pharm launches to the Russian market a unique drug for the MS treatment - Новости GxP","headline":"Valenta Pharm launches to the Russian market a unique drug for the MS treatment - Новости GxP","sentiment":"neutral"}],"patents":[],"drugCount":12,"phaseCounts":{"marketed":4,"phase_3":3,"phase_1":3,"phase_2":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}